A novel case of rhabdoid colon carcinoma associated with a positive CpG island methylator phenotype and BRAF mutation

Human Pathology

Volumn 42, Issue 7, 2011, Pages 1047-1052

  Pancione, Massimo ^a   Di Blasi, Arturo ^b   Sabatino, Lina ^a   Fucci, Alessandra ^a   Dalena, Anna Maria ^b   Palombi, Natalia ^b   Carotenuto, Pietro ^c,d   Aquino, Gabriella ^c,d   Daniele, Bruno ^b   Normanno, Nicola ^c,d   Colantuoni, Vittorio ^a  

^a UNIVERSITY OF SANNIO   (Italy)

^b G RUMMO HOSPITAL   (Italy)

^c Center for Oncology Research   (Italy)

^d NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

CpG island methylator phenotype; Microsatellite instability; Rhabdoid colorectal cancer

Indexed keywords

B RAF KINASE; BETA CATENIN; BEVACIZUMAB; CARCINOEMBRYONIC ANTIGEN; CETUXIMAB; CYCLIN DEPENDENT KINASE INHIBITOR 1B; CYCLIN DEPENDENT KINASE INHIBITOR 1C; CYTOKERATIN 20; CYTOKERATIN 7; EPIDERMAL GROWTH FACTOR RECEPTOR; K RAS PROTEIN; KI 67 ANTIGEN; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; PROTEIN MUTL; PROTEIN P53; TRANSCRIPTION FACTOR CDX2; UVOMORULIN; VIMENTIN;

ABDOMINAL PAIN; ADULT; AGED; ARTICLE; ASCENDING COLON; CANCER CHEMOTHERAPY; CANCER LOCALIZATION; CASE REPORT; COLON ADENOCARCINOMA; COLONOSCOPY; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; CPG ISLAND; DNA METHYLATION; DRUG EFFICACY; EMERGENCY WARD; FEMALE; GASTROINTESTINAL POLYPOSIS; GENE MUTATION; GENETIC ASSOCIATION; HEMICOLECTOMY; HUMAN; HYPERTENSION; IMMUNOHISTOCHEMISTRY; LIVER METASTASIS; LYMPH NODE METASTASIS; MEDICAL HISTORY; MICROSATELLITE INSTABILITY; MULTIPLE CYCLE TREATMENT; PROMOTER REGION; RHABDOID TUMOR; TREATMENT RESPONSE;

AGED; COLONIC NEOPLASMS; CPG ISLANDS; DNA METHYLATION; FEMALE; HUMANS; MICROSATELLITE INSTABILITY; PHENOTYPE; PROTO-ONCOGENE PROTEINS B-RAF; RHABDOID TUMOR;

EID: 79959337448     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2010.10.016     Document Type: Article

References (15)

1. Beckwith JB, Palmer NF. Histopathology and prognosis of Wilms' tumor: results from the First National Wilms' Tumor Study. Cancer 1978;41:1937-48. (Pubitemid 8335406)
2. Haas JE, Palmer NF, Weinberg AG, et al. Ultrastructure of malignant rhabdoid tumor of the kidney: a distinctive renal tumor of children. athol 1981;12:646-57.
3. Wick MR, Ritter JH, Dehner LP. Malignant rhabdoid tumors: a clinicopathologic review and conceptual discussion. Semin Diagn Pathol 1995;12:233-48.
4. Tóth L, Nemes Z, Gomba S, et al. Primary rhabdoid cancer of the ileum: a case report and review of the literature. Pathol Res Pract 2010; 206:110-5.
5. Kono T, Imai Y, Imura J, et al. Cecal adenocarcinoma with prominent rhabdoid feature: report of a case with immunohistochemical, ultrastructural, and molecular analyses. Int J Surg Pathol 2007;15: 414-20. (Pubitemid 47476075)
6. Michael-Robinson JM, Biemer-Hüttmann A, Purdie DM, et al. Tumour infiltrating lymphocytes and apoptosis are independent features in colorectal cancer stratified according to microsatellite instability status. Gut 2001;48:360-6. (Pubitemid 32269564)
7. Pancione M, Forte N, Fucci A, et al. Prognostic role of β-catenin and p53 expression in the metastatic progression of sporadic colorectal cancer. athol 2010;41:867-76.
8. Olsen SH, Thomas DG, Lucas DR. Cluster analysis of immunohistochemical profiles in synovial sarcoma, malignant peripheral nerve sheath tumor, and Ewing sarcoma. Mod Pathol 2006;19: 659-68.
9. Lee S, Cho NY, Yoo EJ, et al. CpG island methylator phenotype in colorectal cancers: comparison of the new and classic CpG island methylator phenotype marker panels. Arch Pathol Lab Med 2008;132: 1657-65.
10. Fox EJ, Leahy DT, Geraghty R, et al. Mutually exclusive promoter hypermethylation patterns of hMLH1 and O6-methylguanine DNA methyltransferase in colorectal cancer. J Mol Diagn 2006;8:68-75. (Pubitemid 43257436)
11. Min KO, Seo EJ, Kwon HJ, et al. Methylation of p16(INK4A) and p57 (KIP2) are involved in the development and progression of gastric MALT lymphomas. Mod Pathol 2006;19:141-8.
12. Deng G, Bell I, Crawley S, et al. BRAF mutation is frequently present in sporadic colorectal cancer with methylated hMLH1, but not in hereditary nonpolyposis colorectal cancer. Clin Cancer Res 2004;10: 10191-5.
13. Ogino S, Kawasaki T, Kirkner GJ, et al. Evaluation of markers for CpG island methylator phenotype (CIMP) in colorectal cancer by a large population-based sample. J Mol Diagn 2007;9:305-14. (Pubitemid 47305066)
14. Issa JP. Colon Cancer: It's CIN or CIMP. Clin Cancer Res 2008;14: 5939-40.
15. Shiratsuchi H, Oshiro Y, Saito T, et al. Cytokeratin subunits of inclusion bodies in rhabdoid cells: immunohistochemical and clinicopathological study of malignant rhabdoid tumor and epithelioid sarcoma. Int J Surg Pathol 2001;9:37-48. (Pubitemid 32295122)